Literature DB >> 12654699

Can Etest be used to determine Vibrio cholerae susceptibility to erythromycin?

Lai-King Ng, Pam Sawatzky, Marcelo Galas, Dalia dos Prazeres Rodrigues, Ingrid Heitmann, Sandra Fernandez, Anne Bolmström.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12654699      PMCID： PMC152522          DOI： 10.1128/AAC.47.4.1479-1480.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  3 in total

1.  Genetic characterization of multidrug-resistant, extended-spectrum- β-lactamase-producing Vibrio cholerae O1 outbreak strains, Mpumalanga, South Africa, 2008.

Authors:  Husna Ismail; Anthony M Smith; Arvinda Sooka; Karen H Keddy
Journal:  J Clin Microbiol       Date:  2011-06-08       Impact factor: 5.948

2.  Efficacy of Ciprofloxacin for Treatment of Cholera Associated with Diminished Susceptibility to Ciprofloxacin to Vibrio cholerae O1.

Authors:  Wasif Ali Khan; Debasish Saha; Sabeena Ahmed; Mohammed Abdus Salam; Michael Louis Bennish
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

3.  Comparative Characterization of Vibrio cholerae O1 from Five Sub-Saharan African Countries Using Various Phenotypic and Genotypic Techniques.

Authors:  Anthony M Smith; Berthe-Marie Njanpop-Lafourcade; Martin A Mengel; Bradford D Gessner; Delphine Sauvageot; Bawimodom Bidjada; Berthe N Miwanda; Diallo M Saliou; Adèle Kacou N'Douba; José P Langa; Husna Ismail; Nomsa Tau; Arvinda Sooka; Karen H Keddy
Journal:  PLoS One       Date:  2015-11-25       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.